Semaglutide: beside supportive care

32 studies: a supportive treatment or test is studied. Page 1 of 1. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.

• A Neuropsychobiological Approach to Optimize Patient Selection for GLP-1-based Pharmacotherapy for Weight Management Across the Binge Eating SpectrumRecruitingNCT07870538Phase 4Report a problem
• HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideNot yet recruitingNCT07760948Phase 2Report a problem
• Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?Not yet recruitingNCT07711548Not applicableReport a problem
• Free Fatty Acid Effects In Type 2 DiabetesEnrolling by invitationNCT07677995Not applicableReport a problem
• Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)Not yet recruitingNCT07621640Not applicableReport a problem
• Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1Not yet recruitingNCT07554417Phase 4Report a problem
• MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal DiseaseRecruitingNCT07478653Not applicableReport a problem
• A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist UseRecruitingNCT07446439Phase 3Report a problem
• Tailored Exercise Training Study Among Adults With HFpEFRecruitingNCT07223242Phase 2/3Report a problem
• Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA TreatmentRecruitingNCT07213323Not applicableReport a problem
• A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 DiabetesRecruitingNCT07195994Not applicableReport a problem
• Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection FractionRecruitingNCT07178145Phase 4Report a problem
• Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With ObesityRecruitingNCT07091500Not applicableReport a problem
• Rebalancing the Fat Content of the Heart and MusclesRecruitingNCT07065383Not applicableReport a problem
• Prevent and Reverse Obesity in Children, Adolescents and Young AdultsNot yet recruitingNCT07035704Not applicableReport a problem
• Protein Supplementation Intervention on Body WeightRecruitingNCT06989203Not applicableReport a problem
• GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way ForwardNot yet recruitingNCT06977438Phase 4Report a problem
• LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide TherapyRecruitingNCT06885736Not applicableReport a problem
• The Evira Study: Additional Support During Obesity TreatmentRecruitingNCT06836284Not applicableReport a problem
• Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With SemaglutideRecruitingNCT06497595Not applicableReport a problem
• Monitoring Patients With Severe Obesity Treated With Wegovy® Using Connected Device: Real-world DataNot yet recruitingNCT06426446Not applicableReport a problem
• GENETIC VARIABILITY TO GLP1 TREATMENTRecruitingNCT06298799Not applicableReport a problem
• Probiotics in Obese Patients Treated With SemaglutideCompletedNCT07847593Not applicableReport a problem
• Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight LossCompletedNCT07280403Not applicableReport a problem
• Effect of Itopride on Semaglutide GastroparesisCompletedNCT07254715Phase 4Report a problem
• Tolerance of a High Protein Nutrition Shake in Individuals on GLP-1CompletedNCT07096739Not applicableReport a problem
• A Study of a Novel Precision Medicine Approach For ObesityActive, not recruitingNCT06814938Phase 4Report a problem
• A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist UseCompletedNCT06804603Phase 2Report a problem
• A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) AgonistCompletedNCT06500429Phase 2Report a problem
• Gastric Ultrasound To Assess Gastric Contents In Patients On Semaglutide TherapyCompletedNCT06292065Not applicableReport a problem
• Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or ObesityCompletedNCT06215196Not applicableReport a problem
• The Effect of Different Diets on Arterial Stiffness in Obese Patients on SemaglutideCompletedNCT04990024Not applicableReport a problem

← Semaglutide